Bangor Savings Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Bangor Savings Bank’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.14K	Hold	100	–	–	﹤0.01%	488
2026 Q1	$2.48K	Hold	100	–	–	﹤0.01%	511
2025 Q4	$2.33K	Hold	100	–	–	﹤0.01%	565
2025 Q3	$1.97K	Hold	100	–	–	﹤0.01%	511
2025 Q2	$2.17K	Hold	100	–	–	﹤0.01%	502
2025 Q1	$2.42K	Hold	100	–	–	﹤0.01%	492
2024 Q4	$2.09K	Hold	100	–	–	﹤0.01%	516
2024 Q3	$1.99K	Hold	100	–	–	﹤0.01%	512
2024 Q2	$1.55K	Hold	100	–	–	﹤0.01%	486
2024 Q1	$1.59K	Hold	100	–	–	﹤0.01%	476
2023 Q4	$1.68K	Hold	100	–	–	﹤0.01%	479
2023 Q3	$1.17K	Hold	100	–	–	﹤0.01%	506
2023 Q2	$1.34K	Hold	100	–	–	﹤0.01%	507
2023 Q1	$1.66K	Hold	100	–	–	﹤0.01%	503
2022 Q4	$2K	Hold	100	–	–	﹤0.01%	495
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	509
2022 Q2	$1K	Buy	+100	New	+$733	﹤0.01%	498

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bangor Savings Bank's CPRX Position: Q2 2026 in Review

Bangor Savings Bank held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 100 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Bangor Savings Bank first reported a position in CPRX in Q2 2022 and has held it in 17 quarters since. 35 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Bangor Savings Bank held 100 shares of Catalyst Pharmaceutical worth $3.14K as of Q2 2026.
Bangor Savings Bank left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Bangor Savings Bank's portfolio in Q2 2026, its #488 holding.
Bangor Savings Bank first reported a position in Catalyst Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
35 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.